v3.26.1
Related party transactions (Details) - CHF (SFr)
1 Months Ended 12 Months Ended 24 Months Ended
Apr. 02, 2024
Jun. 30, 2025
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2025
Related party transactions            
Salaries, other short-term employee benefits and post-employment benefits     SFr 474,976 SFr 341,575 SFr 159,775  
Consulting fees         17,106  
Share-based compensation     69,850 167,066 239,202  
Key management compensation     544,826 508,641 416,083  
Neurosterix US Holdings LLC            
Related party transactions            
Percentage of equity interest received 20.00%          
Discontinued operations            
Related party transactions            
Salaries, other short-term employee benefits and post-employment benefits       664,525 1,484,290  
Share-based compensation       1,260,638 1,297,695  
Key management compensation       1,925,163 SFr 2,781,985  
Discontinued operations as disclosed below            
Related party transactions            
Cash in from Neurosterix Pharma Sarl sale SFr 5,000,000     5,000,000   SFr 5,000,000
Fair value of Neurosterix US Holdings LLC's participation SFr 9,420,000     9,428,400   9,400,000
Fair value of service agreement     141,018 SFr 182,348    
Discontinued operations as disclosed below | Neurosterix US Holdings LLC            
Related party transactions            
Percentage of equity interest received 20.00%     20.00%    
Board of directors and executive management            
Related party transactions            
Net payable     SFr 100,000 SFr 100,000   SFr 100,000
Neurosterix Group            
Related party transactions            
Net receivable       SFr 7,967    
Stalicla SA            
Related party transactions            
Investment in Stalicla SA   SFr 795,029        
Preferred shares received on investment in Stalicla SA   23,342